Sinopharm Benefits From Strong GDP Growth

China's largest pharmaceutical distribution firm, Sinopharm, has released healthy financial results for the year ended December 31 2009. Sales increased by 23.2% to CNY47.05bn (US$6.89bn) and profit jumped by 44.6% to CNY1.19bn (US$174mn). Most importantly, the operating profit margin increased from 3.07% to

To read the full article, please choose one of the following options: